Expression of FOXP1 in mucosa-associated lymphoid tissue lymphoma suggests a large tumor cell transformation and predicts a poorer prognosis in the positive thyroid patients

Medical Oncology

Volumn 29, Issue 5, 2012, Pages 3352-3359

  Jiang, Wei ^a,b   Li, Lei ^a,b   Tang, Yuan ^a   Zhang, Wen Yan ^a   Liu, Wei Ping ^a   Li, Gan Di ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

FOXP1; Lymphoma; MALT lymphoma; Neoplasm; Prognosis

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, HUMAN; REPRESSOR PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MEDICAL RECORD REVIEW; PLASMA CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; THYROIDITIS; TUMOR CELL; WESTERN BLOTTING; AGED; BIOSYNTHESIS; CANCER STAGING; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; THYROID TUMOR; TISSUE MICROARRAY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880271164     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0288-7     Document Type: Article

References (22)

1. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue(MALT-) type. Cancer Res. 1997;57:3944-8.
2. Wotherspoon AC, Pan LX, Diss TC, et al. Cytogenetic study of B-cell Lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet. 1992;58:35-8.
3. Streubel B, Lamprecht A, Dierlamm J, et al. T(11;14)(p22;q32) involving IGH and MALT1 is a frequent chromosome aberration in MALT lymphoma. Blood. 2003;101:2334-9.
4. Liu H, Hamoudi RA, Ye H, et al. t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. Br J Haematol. 2004;125:318-29.
5. Achuthan R, Bell SM, Leek JP, et al. Novel translocation of the bcl-10 gene in a case of mucosa associated lymphoid tissue lymphoma. Genes Chromosomes Cancer. 2000;29:347-9.
6. Du MQ, Peng H, Liu H. bcl-10 gene mutation in lymphoma. Blood. 2000;95:3885-90.
7. Streubel B, Vinatzer U, Lamprecht A, et al. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005;19:652-8.
8. Weigel D, Jürgens G, Küttner F, et al. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell. 1989;57:645-58.
9. Carlsson P, Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol. 2002;250:1-23.
10. Wang B, Lin D, Li C, et al. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem. 2003;278:24259-68.
11. Banham AH, Beasley N, Campo E, et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 2001;61:8820-9.
12. Hu H, Wang B, Borde M, et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 2006;7:819-25.
13. Wang B, Weidenfeld J, Lu MM, et al. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development. 2004;131:4477-87.
14. Fox SB, Brown P, Han C, et al. Expression of the forkhead transcription factor FOXP1 is associated with estrogen α and improved survival in primary human breast carcinomas. Clin Cancer Res. 2004;10:3521-7.
15. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-82.
16. Barrans SL, Fenton JAL, Banham AH, et al. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma(DLBCL) patients with poor outcome. Blood. 2004;104:2933-5.
17. Banham AH, Connors JM, Brown PJ, et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res. 2005;11:1065-72.
18. Sagaert X, Paepe PD, Libbrecht L, et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:2490-7.
19. Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. p. 214-9.
20. Jiang W, Li GD, Li L, et al. Clonal relationship between transformed and non-transformed components in mucosa-associated lymphoid tissue lymphoma. [article in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2007;36:736-41.
21. Hoeller S, Schneider A, Haralambieva E, et al. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1. Histopathology. 2010;57:73-80.
22. Choi W, Weisenburger D, Greiner T, et al. A new immunostain algorithm classifies diffuse large B-Cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15:5494-502.